Market Scenario:
Congenital adrenal hyperplasia is an inherited genetic
disorder affects the adrenal glands. The patient suffering from these disorders
lacks CAH enzymes which help in the production of hormones that help regulate
metabolism, the immune system, blood pressure and other essential physiological
functions. These disorders most commonly occur in children and infants. A
number of the diagnostic tests are available in the market for the diagnosis of
these disorders. According to the National Institute of Child Health and Human
Development (2015), about one in 18,000 children suffer from congenital adrenal
hyperplasia each year. The global congenital adrenal hyperplasia market is
majorly driven by the increasing prevalence of the disorder, unmet needs for
the treatment of the genetic disorders and rising demand for better and
effective medicines for the treatment. Moreover, increasing government support
and rapid developments in technology have fueled the growth of the market. The
absolute treatment of congenital adrenal hyperplasia is not available in the
market. High cost of the treatment and unavailability of precise treatment may
slow the growth of the market.
The global congenital adrenal hyperplasia market is
expected to grow at a CAGR of ~7.1 % during the forecast period
2017-2023.
Get
Exclusive Sample Report @
https://www.marketresearchfuture.com/sample_request/4946
Segmentation:
The global congenital adrenal hyperplasia market is segmented
on the basis of types, diagnosis & treatment and end users.
On the basis of types, the market is segmented into classic
CAH, and non-classic CAH.
On the basis of diagnosis & treatment, the market is
segmented into diagnosis and treatment. Diagnosis is further segmented into
amniocentesis, chorionic villus sampling, blood and urine tests, gene testing,
physical exam, and others. Treatment is sub-segmented into medications and
surgery. Medications are again segmented into glucocorticoids,
mineralocorticoids, salt supplements, and others.
On the basis of end users, the market is segmented into
hospital, clinics and others.
Intended
Audience:
·
Pharmaceutical and Biotechnological Companies
·
Research and Development (R&D) Companies
·
Neurological Companies
·
Hospitals and Clinics
·
Academic Institutes and Universities
Regional
Analysis:
The Americas dominate the global congenital adrenal
hyperplasia market owing to the increasing number of patients with congenital
adrenal hyperplasia, and genetic disorders. Due to rapidly increasing patient
population, governments have started supporting the manufacturers for the
development of new and better drugs. Additionally, well-developed technology,
high healthcare expenditure, and strong government support for research &
development have fueled the growth of the market in this region.
On the other hand, the Middle East & Africa holds the
least share of the market owing to less availability of funds, limited
availability of medical facilities, and poor political conditions in Africa.
The Middle East region holds the major share in the market owing to
well-developed technology, and high healthcare expenditure. On the other hand,
Africa region shows the fastest growth due to the availability of opportunities
for the market growth.
Key Players:
Some of key the players in the market are Neurocrine
Biosciences, Inc. (U.S.), Fusion IP plc (U.K), Novartis AG (Switerzland),
Mitsubishi Chemical Holdings Corporation (Japan), Johnson & Johnson (U.S.),
GlaxoSmithKline Plc (U.S.), Cadila healthcare (India), Sanofi (France),
Macleods Pharmaceuticals (India), GlaxoSmithKline Plc. (U.K), Allergan
(Ireland), Abbott (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly
and Company (U.S.), AstraZeneca Plc. (U.K), Merck & Co., Inc. (U.S.)
Get Your
Customized Report @ https://www.marketresearchfuture.com/reports/congenital-adrenal-hyperplasia-market-4946
Table of
Content:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
TOC
Continued…!
Get Discount
@https://www.marketresearchfuture.com/check-discount/4946
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone:
+1
646 845 9312
No comments:
Post a Comment